Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet

This study has been completed.
Veeda Clinical Research
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) ) Identifier:
First received: February 26, 2010
Last updated: February 4, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)